Cargando…
Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
Glioblastoma multiforme is the most common and aggressive primary brain tumor. Even with aggressive treatment including surgical resection, radiation, and chemotherapy, patient outcomes remain poor, with five-year survival rates at only 10%. Barriers to treatment include inefficient drug delivery ac...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359729/ https://www.ncbi.nlm.nih.gov/pubmed/30654536 http://dx.doi.org/10.3390/nano9010105 |